Profitability Metrics

Gross Margin
23.30%
Operating Margin
7.62%
Net Margin
6.05%

Efficiency Metrics

Revenue per Expense Ratio
1.08
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
11.50%
Income Tax Rate
22.49%
EPS
3.2500000000

Balance Sheet Analysis

Current Ratio
1.79
Cash Ratio
1.05
Working Capital
$739.64M
Debt to Equity
0.33
Debt to Assets
15.77%
Equity Ratio
47.11%

Cash Flow Analysis

Operating Cash Flow Ratio
10.16%
Free Cash Flow Ratio
8.19%
CapEx to Revenue
1.97%
Dividends Paid
$54.39M
Stock Buybacks
$53.16M
Total Shareholder Returns
$107.55M
Cash Position Change
11.49%

Key Takeaways (2024 FY)

  • Revenue declined by 2.3859955667852%, indicating potential market challenges
  • Increased dividend payments by 66.40%

Detailed Growth Metrics

Core Performance

Revenue
-2.39%
Net Income
-19.27%
EPS
-18.34%
Operating Income
-32.69%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
-88.06%
Operating Cash Flow
-17.43%
Free Cash Flow
-16.34%

Balance Sheet Health

Assets
2.92%
Debt
3.39%
Book Value per Share
6.02%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
66.40%
Shares Outstanding
-0.86%

Long Term Trends

3Y Revenue/Share
59.29%
5Y Revenue/Share
53.48%
3Y Dividend/Share
150.71%
5Y Dividend/Share
151.27%